Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma <i>via</i> the combination therapy with FOXM1 inhibitor RCM1.

Donovan, Johnny; Deng, Zicheng; Bian, Fenghua; Shukla, Samriddhi; Gomez-Arroyo, Jose; Shi, Donglu; Kalinichenko, Vladimir V; Kalin, Tanya V

Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1.

Donovan, Johnny; Deng, Zicheng; Bian, Fenghua; Shukla, Samriddhi; Gomez-Arroyo, Jose; Shi, Donglu; Kalinichenko, Vladimir V; Kalin, Tanya V.

Afiliação

Donovan J; Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Deng Z; Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Bian F; The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Shukla S; Center for Lung Regenerative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Gomez-Arroyo J; Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Shi D; Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Kalinichenko VV; Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Kalin TV; Division of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, United States.

Front Oncol ; 13: 1163510, 2023.

Article em En | MEDLINE | ID: mdl-37124500

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.3389/fonc.2023.1112859.].

Palavras-chave

FOXM1 inhibitor; animal models; combination therapy; nanoparticles; rhabdomyosarcoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos